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Background:  Rotaviruses  are  the  major  cause  of diarrhea  in children  for which  a monovalent  G1P[8]
vaccine  has  been  provided  free  for all Brazilian  infants  since  March  2006.
Objectives:  To  investigate  prevalence  and  genotypes  of  rotavirus  strains  causing  diarrhea  in children  in
Triângulo  Mineiro,  Minas  Gerais,  during  2007–2010,  and  to  assess  local  vaccine  impact.
Study  design:  Fecal  specimens  were  analyzed  for rotavirus  detection  and characterization  by  PAGE, RT-PCR
and PCR-genotyping  assays.
Results:  Overall,  rotavirus  was  diagnosed  in  12.1%  (76/630)  cases,  accounting  for  35.8%  of the  hospitaliza-
tions  and  6.5%  of  outpatient  attendance  due  to  diarrhea.  A  trend  in  rotavirus  disease  reduction  occurred
in both  cities  (71.8%  and 83.4%  in Uberaba;  95.3%  in  Uberlândia)  up to 2009,  but  it reversed  in 2010  with
increased  rotavirus  cases  in  Uberlândia.  Short  pattern  G2P[4]  strains  were  detected  in  all  but  three  (96%)
cases  of  mixed/P[NT]  infections  with  long  electropherotypes.
Conclusions: This  4-year  follow-up  study  showed  a  reduction  in  rotavirus-related  diarrhea  and  even
skipped  a rotavirus  season,  which  is consistent  with  vaccine  mediated  protection.  The  2007–2010
rotavirus  epidemic  curve  reﬂected  the  natural  cyclic  ﬂuctuation  of  the  single G2P[4]  genotype,  with
sharp  reduction  of cases  in  2008  leading  to lack  of  a rotavirus  2009  season  (both  cases  and  hospitaliza-
tions)  followed  by its come  back  in  2010.  Diarrhea  cases  related  to either  vaccine  serotype/genotype  (G1
or P[8])  were  not  detected.  Thus,  a  new  scenario  emerged  with  a  single  epidemic  genotype  replacing
the  cocirculation  of  great  diversity  of  genotypes,  thus  far,  a hallmark  of  the  epidemiology  of  rotavirus  in
Brazil.. Background
Group A rotavirus, member of genus Rotavirus, family Reoviri-
ae, is the major cause of acute infectious diarrhea in children
nd a serious public health problem in the world.1 The use of an
ffective rotavirus vaccine to signiﬁcantly reduce the incidence
f severe disease has been advocated for decades.2 The virus has genome composed by 11 segments of double-stranded RNA
ith a high potential for reassortment during mixed infections,
 relatively common event in enterically transmited diseases.3
Abbreviations: PAGE, polyacrylamide gel electrophoresis; RT-PCR, reverse
ranscription-polymerase chain reaction; RNA, ribonucleic acid; VP, viral protein;
T, non-typed.
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Rotavirus infects humans and several animal species producing
diarrheal disease; presents a great diversity of serotypes which
are based on a dual antigenic system composed by the outer
capsid protein VP7 (G serotype) and the virus spike protein VP4
(P serotype); and both proteins independently elicit neutraliz-
ing antibodies.1 Most epidemiologic surveys have used molecular
assays (genotyping) to identify the rotavirus serotypes present in
clinical specimens, and found that serotypes/genotypes G1P[8],
G2P[4], G3P[8], G4P[8], and more recently, also G5P[8], G8P[6]
and G9P[8] have been the ones responsible for major outbreaks
or epidemics of diarrheal disease in humans.1 On March 2006,
an attenuated monovalent G1P[8] vaccine strain (Rotarix®, GSK,
Belgium) was  introduced into the childhood immunization pro-
gram of the Brazilian Public Health System (SUS). A survey on
the frequency and distribution of rotavirus genotypes causing
Open access under the Elsevier OA license.gastroenteritis in infants and children in the Triângulo Mineiro
region of Minas Gerais has been underway since September 2005.
Results from six months prior to and early after the launching of
country-wide rotavirus immunization have been published.4 Here
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e report the results obtained during the 4-year follow up study
2007–2010).
. Objectives
To investigate the prevalence and genotypes of rotavirus strains
ausing diarrhea in children in Triângulo Mineiro, Minas Gerais,
uring 2007–2010, and to investigate possible vaccine impact on
he epidemiology of rotavirus gastroenteritis in the region.
. Study design
.1. Patients and specimens
Fecal specimens from children up to ten years of age, clini-
ally diagnosed with acute diarrhea were collected in two centers:
aboratório Jorge Furtado Medicina Diagnóstica (LJF) in Uberaba
nd IPAC Medicina Diagnóstica (IPAC) in Uberlândia. These lab-
ratories collect and analyze specimens from private and public
ospitals and pediatric clinics from the Triângulo Mineiro region.
amples from Uberaba represent the 2007–2009 period and from
berlândia the 2008–2010 period. Uberaba (∼296,000 inhabitants)
nd Uberlândia (∼600,000 inhabitants) are the largest cities of the
ig. 1. (A) Temporal distribution of diarrhea and rotavirus-associated cases in Uberaba, 2
berlândia, 2008–2010.ical Virology 55 (2012) 67– 71
Triângulo Mineiro region in West Minas Gerais. They are approxi-
mately 100 km apart from each other, share high living standards
and other social, economical and environmental conditions, but dif-
fer in other features. Although presently booming, older, historic
and rural Uberaba is an important center of grain production and
cattle breeding, in contrast to the urban, industrial and service-
oriented Uberlândia.
3.2. Rotavirus detection and characterization
Fecal specimens were submitted to nucleic acid extraction,5
PAGE6,7 and silver staining.8 Positive specimens were characterized
by RT-PCR ampliﬁcation, and PCR-typing assays.9–12
4. Results
A  total of 630 specimens were received between April 2007
and December 2010: all were tested for rotavirus. They were col-
lected continuously from April 2007 to December 2009 in Uberaba
and from May  2008 to December 2010 in Uberlândia (Fig. 1A and
B). Overall, 76 (12.1%) specimens were positive for rotavirus, all
detected during the coldest and dry period of each year. Rotavirus
contributed with 35.8% of diarrhea hospitalizations and 6.5% of
007–2009. (B) Temporal distribution of diarrhea and rotavirus-associated cases in
A.C.B. Dulgheroff et al. / Journal of Clinical Virology 55 (2012) 67– 71 69
Table 1
Distribution of acute gastroenteritis and rotavirus-related cases in hospitalized
patients and outpatients in Uberaba during rotavirus season (May to December),
and non-rotavirus season (January to April), 2007–2009.
Period No. positive samples/No. samples tested (%)
Inpatient Outpatient Total
2007
May–December 24/60 (40.0) 9/33 (27.3) 33/93 (35.5)
January–Aprila 0/2 (0.0) 0/3 (0.0) 0/5 (0.0)
2008
May–December 1/5 (20.0) 4/45 (8.9) 5/50 (10.0)
January–April 0/1 (0.0) 0/27 (0.0) 0/28 (0.0)
2009
May–October 0/0 (0.0) 1/17 (5.9) 1/17 (5.9)
January–April 0/6 (0.0) 0/15 (0.0) 0/21 (0.0)
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Fig. 2. Percentage of diarrheal disease according to patients’ age group in the Triân-
gulo Mineiro region, MG.Total 25/74 (33.8) 14/140 (10.0) 39/214(18.2)
a There were no samples from January to March.
utpatient attendance for diarrhea in both cities during the study
eriod.
Unexpectedly large numbers of diarrhea cases were seen dur-
ng the summer months (January–March), a non-rotavirus period,
n which no rotavirus case was recorded. Thus, only comparable
eriods (May–December) comprising the rotavirus seasons were
onsidered for prevalence calculations. The distribution of samples
nd prevalence of rotavirus-associated diarrhea in hospitalized and
on-hospitalized patients in the two collection centers are shown
n Tables 1 and 2. There was a substantial decrease in the prevalence
f rotavirus cases during the rotavirus seasons in both cities up to
009: it dropped from 35.5% in 2007 to 10% in 2008 and 5.9% in 2009
n Uberaba; and from 19% in 2008 to 0.9% in 2009 in Uberlândia.
owever, this trend was  reversed the following year in Uberlândia
ith an increased rotavirus prevalence of 20.5% in 2010.
Overall, for the two sites combined, rotavirus contribution to
ospital admissions was 42.2% (43/102) whereas rotavirus com-
rised only 9.2% (33/357) of the outpatient cases of gastroenteritis
uring the rotavirus seasons. Children aged 7–12 month-old com-
osed the group most affected by acute diarrheal disease regardless
f the cause (Fig. 2). However, the distribution of rotavirus-related
ases varied somewhat over time showing a tendency to affect older
hildren, especially in 2007 and 2008 (Fig. 3).
All rotavirus-positive specimens presented characteristic group
 electrophoretic patterns: 73 (96%) samples showed short pat-
ern with at least three variants, and only three samples showed
ong patterns, each one showing a unique proﬁle. The short pat-
ern samples were all identiﬁed as genotype G2P[4] whereas the
ong proﬁles corresponded to mixed infections or incompletely
yped strains and included the only two rotavirus cases detected
n 2009: a G5G10P[NT] in Uberaba and a G3P[NT] in Uberlândia;
able 2
istribution of acute gastroenteritis and rotavirus-related cases in hospital-
zed patients and outpatients from Uberlândia during rotavirus season (May to
ecember), and non-rotavirus season (January to April), 2008–2010.
Period No. positive samples/No. samples tested (%)
Inpatient Outpatient Total
2008
May–December 8/14 (57.1) 12/91 (13.2) 20/105 (19.0)
January–Aprila 0/0 () 0/0 (0.0) 0/0 (0.0)
2009
May–December 0/12 (0.0) 1/104 (1.0) 1/116 (0.9)
January–April 0/5 (0.0) 0/40 (0.0) 0/45 (0.0)
2010
May–December 10/11 (90.9) 6/67 (9.0) 16/78 (20.5)
January–April 0/4 (0.0) 0/68 (0.0) 0/72 (0.0)
Total 18/46 (39.1) 19/370 (5.1) 37/416 (8.9)
a There were no samples from January to April.Fig. 3. Percentage of rotavirus cases according to patients’ age group in the Triângulo
Mineiro region, MG.
the third long proﬁle, a G3P[8]P[4], was detected in 2008 in Uber-
lândia. Those three cases were outpatients aged 3–4 years old who
were not eligible for vaccination.
5. Discussion
Rotavirus infections occurred in the winter months as usually
observed for Southeastern Brazil4,13–17 and most of the world.1
Overall, the detection rate of rotavirus in this study (12.1%) was  sim-
ilar to the 2005–2006 period (15%) in the same region4 and within
the range of 8–23% described in a recent review of 49 Brazilian
studies.18 Nevertheless, the present study showed a striking decline
in rotavirus-associated cases over the three seasons in Uberaba,
with reductions of 71.8% and 83.4% in 2008 and 2009, respectively,
and over the ﬁrst two  seasons in Uberlândia, with 95.3% reduction
in 2009 when compared to 2008. Thus, the year of 2009 was  quite
unique in the Triângulo Mineiro region for the lack of a rotavirus
season. In contrast with this large reduction observed in rotavirus
cases, the number of non-rotavirus diarrhea cases did not decreased
over time in Uberlândia (Fig. 1B), eliminating the possibility of bias
due to specimen collection. In the following 2010 season, how-
ever, Uberlândia experienced a resurgence of rotavirus-associated
cases, going back to the 2008 level of rotavirus diarrhea cases and
hospitalizations. A substantial reduction in rotavirus activity in
one season followed by resurgence in the next season has also
been reported in the United States after vaccine introduction.19
Despite reduction in rotavirus-related cases, a signiﬁcant number
of non-rotavirus diarrheas were observed throughout the study
period with no apparent seasonality or diminished frequency over
time, reﬂecting the need to search for other agents of infantile
gastroenteritis.
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Previous data on rotavirus-associated disease in Uberaba span-
ing from about 6 months before and 10 months after vaccine
ntroduction have shown long pattern G1P[8], G4P[8], G9P[8] and
?P[8] strains co-circulating in 2005–2006 and the emergence of
hort pattern G2P[4] strains by mid-2006.4 In the present follow-
p study, the ﬂuctuation of G2P[4] genotype was well deﬁned
gainst a background devoid of long pattern P[8] strains, reach-
ng its epidemic peak in 2007 and waning afterward, completing a
ypical 2–3 year prevalence cycle for this serotype. Unfortunately,
amples from Uberaba, were no longer available after 2009. The 3-
ear survey conducted in Uberlândia began later, but the results
f the two overlapping years (2008–2009) were very similar to
hose of Uberaba: genotype G2P[4] also predominated in 2008 and
as undetected in 2009; however, in 2010, this genotype made
 comeback, increasing the prevalence of rotavirus primarily in
ospitalized patients. This probably represents an unexpected con-
inuation of the G2P[4] epidemic cycle in the region. A 2–3-year
eriod of predominance followed by longer 6–10-year interval of
bsence, or only sporadic detection, of G2P[4] strains was  well
escribed in Australia20 and constitutes a hallmark of the epidemi-
logy of distinct rotavirus serotypes.1,21
The absence of diarrhea cases exclusively related to genotype
[8] strains (G1 or non-G1) in the current study seems to indicate
accine protection against homotypic (P[8]) rotavirus, regardless
f the G type. In fact, clinical trials have demonstrated high (>87%)
fﬁcacy of Rotarix vaccine to protect against rotaviruses of the
ost prevalent G types associated with P[8].22–24 Nevertheless, this
otentially vaccine driven effect observed just one year (2007) into
he program, and sustained for at least four years in the Triângulo
ineiro region was quite remarkable. The changing pattern of cir-
ulating rotavirus types, with greatly reduced diversity of strains
ssociated with disease since 2007 may  have important impli-
ations for the evolution of rotavirus strains. However, distinct
esults in vaccine impact on the distribution of rotavirus geno-
ypes were reported from Australia after the introduction of Rotarix
n 200725,26: G1P[8] predominated (largely due to an outbreak
n the Northern Territory in 2010) followed by G2P[4]; the other
ommon genotypes (G3P[8], G4P[8], G9P[8]) continued to circu-
ate marginally; uncommon genotype combinations were detected
ore frequently than in pre-vaccine periods, thus suggesting a
ocal increase in strain diversity. Interestingly, genotype G2P[4] was
lso the second most prevalent genotype detected in those Aus-
ralian states that were using another rotavirus vaccine (Rotateq) in
heir program. Thus, emergence of G2P[4] in Australia25 and other
ountries,27–29 as in Brazil,4,15,30–33 most likely follows a global
rend dictated by the oscillatory ﬂuctuations of rotavirus genotypes
eemingly unrelated to vaccination.
While efﬁcacy of Rotarix against G2P[4] was low (42%) in clinical
rials,22,24 a follow-up study in Europe23 demonstrated good efﬁ-
acy against gastroenteritis caused by G2P[4] strains; and a recent
linical trial conducted in Africa provided further evidence that
otarix affords similar protection against gastroenteritis caused
y G1 and non-G1 rotavirus strains.34 Likewise, a case–control
tudy from Recife, Brazil35 reported 77% vaccine efﬁcacy against
2P[4] hospitalizations of infants between 6 and 12 months of
ge, although vaccination did not change the risk of hospitaliza-
ion in older children. Lack of information on child’s vaccination
tatus was a limitation in the current study, nevertheless, based on
he child’s age at illness, 50.7% of children infected with G2P[4]
trains (1/3 of those infected in 2007; 2/3 in 2008; and all in
010) were eligible for vaccination. The mean vaccine coverage
ate was 86% for the state of Minas Gerais in the 2007–2010 period
http://tabnet.datasus.gov.br).
There was a higher prevalence (42%) of rotavirus-related diar-
hea in hospitalized patients than in outpatients (9.2%), conﬁrming
hat rotavirus is the major contributor to hospitalization of childrenical Virology 55 (2012) 67– 71
due to diarrhea.1 A relatively high prevalence of rotavirus cases was
observed in children over 24 months of age at the epidemic peak
in 2007 and in 2008, which may  reﬂect the recent introduction
of G2P[4] in the region after an interval of absense,4 thus ﬁnd-
ing a large number of older children previously unexposed to this
serotype. It is also possible that older children were less likely to
be vaccinated than younger children. In 2010, children between 13
and 48 months were also the most affected during the resurgence
of G2P[4] in Uberlândia.
Long proﬁle non-G1, non-P[8] strains were detected in just three
odd cases of untypable P and/or mixed infections presenting typi-
cal animal G genotypes that have been associated with outbreaks
of gastroenteritis in humans in several parts of the world (G3), in
Asia (G10), or in Brazil (G5).1,36,37 Of interest, a mixed infection
G3P[8]P[4] was  identiﬁed in 2008 and a G3P[NT] strain in 2009,
both in Uberlândia; they may  represent thresholds of still unsuc-
cessful reassortants or recent animal transmission.
This 4-year follow-up study showed a reduction in rotavirus-
related diarrhea and even skipped a rotavirus season (2009), which
is consistent with vaccine mediated protection. A new scenario
emerged with the disappearance of homotypic (G1 or P[8]) strains
related to diarrhea cases, thus reducing the great diversity of strains
of distinct genotypes co-circulating simultaneously which, thus far,
constituted a hallmark of the epidemiology of rotavirus in Brazil.3,15
The coincidental rise and spread of G2P[4] in post-vaccination
period resulted in a simpliﬁed epidemiology, resembling that
described in the twentieth century for United States and Europe1
but seldom seen in pre-vaccination cities in Brazil. The conse-
quences of vaccination on the epidemiology of rotavirus infections
are still unpredictable, taking into account the very diverse nature
of the virus and its great ability to reassort.3 Continued genotype
surveillance should provide better understanding of rotavirus evo-
lution and assessment of the vaccine program.
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